返回ChemicalBook首页>CAS数据库列表>2344825-52-9

2344825-52-9

中文名称 化合物 XP-524
英文名称 Ethanesulfonamide, N-[6-(6,7-dihydro-1-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridin-3-yl)-1-(1,1-di-2-pyridinylethyl)-1H-indol-4-yl]-
CAS 2344825-52-9
分子式 C30H28N6O3S
分子量 552.65
MOL 文件 2344825-52-9.mol
2344825-52-9 结构式 2344825-52-9 结构式

基本信息

中文别名
化合物 XP-524
英文别名
Ethanesulfonamide, N-[6-(6,7-dihydro-1-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridin-3-yl)-1-(1,1-di-2-pyridinylethyl)-1H-indol-4-yl]-

物理化学性质

密度1.36±0.1 g/cm3(Predicted)
酸度系数(pKa)9.13±0.30(Predicted)
形态Solid
颜色Light yellow to light brown

应用领域

用途一
XL-223 is a potent BET inhibitor effective in endocrine-resistant ER+ breast cancer with acquired resistance to fulvestrant and palbociclib. XL-223 was more potent in MCF-7:CFR cells than six BET inhibitors in clinical trials. Transcriptomic analysis differentiated XL-223 from the benchmark BETi, JQ-1, showing downregulation of oncogenes and upregulation of tumor suppressors and apoptosis. The therapeutic approach was validated by oral administration of XL-223 in orthotopic xenografts of endocrine-resistant breast cancer in monotherapy and in combination with fulvestrant. Importantly, at an equivalent dose in rats, thrombocytopenia was mitigated.

常见问题列表

概述
XP-524 是一种有效的 BET 和 EP300 抑制剂。XP-524 在体内显示出强大的杀肿瘤活性。 XP-524 可防止 KRAS 诱导的体内肿瘤转化,并延长两种侵袭性 PDAC 转基因小鼠模型的存活时间。XP-524 还增强了自身肽的表达和将肿瘤细胞向细胞毒性 T 淋巴细胞的募集。XP-524 具有研究胰腺导管腺癌(PDAC)的潜力。
"2344825-52-9" 相关产品信息